- Current recommendations for the treatment of non -small-cell lung cancer with special focus to therapy of advanced NSCLC according to ESMO and NCCN guidelines and Blue Book2015 | Publication without faculty affiliation
- New options of expensive pneumo-oncological therapy for advanced non-small-cell lung carcinoma (NSCLC) in the first line based on morphological and molecular genetic diagnosis in the Czech Republic2012 | Central Library of Charles University, Faculty of Medicine in Pilsen, First Faculty of Medicine
- New options for biologically targeted therapy of advanced non-small-cell lung cancer - sunitinib and sorasfenib2010 | Central Library of Charles University
- First-line immunotherapy in NSCLC - what brought 20182018 | Faculty of Medicine in Pilsen
- EGFR mutations in patients with advanced NSCLC2012 | Faculty of Medicine in Pilsen
- Strategie léčby metastatického onemocnění - nesquamózního nemalobuněčného karcinomu plic bez řídící mutace2016 | Publication without faculty affiliation
- KRAS (G12S) mutation in a patient with NSCLC treated with erlotinib – a case report2013 | Faculty of Medicine in Pilsen
- Atezolizumab in the treatment of lung cancer2020 | Publication without faculty affiliation
- Is anticancer immunotherapy break-trough in lung cancer therapy?2019 | First Faculty of Medicine
- Is anticancer imunotherapy break-trough in lung cancer therapy?2020 | First Faculty of Medicine